Login / Signup
Peter Wung
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Ankylosing Spondylitis
Clinical Trial
Extracorporeal Membrane Oxygenation
Electronic Health Record
Top Venues
Clinical and translational science
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sumit Bhatnagar
,
Doerthe Eckert
,
Sven Stodtmann
,
In-Ho Song
,
Peter Wung
,
Wei Liu
,
Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.
Clinical and translational science
17 (2) (2024)
Sumit Bhatnagar
,
Doerthe Eckert
,
Sven Stodtmann
,
In-Ho Song
,
Peter Wung
,
Wei Liu
,
Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis.
Clinical and translational science
17 (2) (2024)
Sumit Bhatnagar
,
Doerthe Eckert
,
Sven Stodtmann
,
In-Ho Song
,
Peter Wung
,
Wei Liu
,
Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis.
Clinical and translational science
17 (2) (2024)
Sumit Bhatnagar
,
Doerthe Eckert
,
Sven Stodtmann
,
In-Ho Song
,
Peter Wung
,
Wei Liu
,
Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.
Clinical and translational science
17 (2) (2024)
Sumit Bhatnagar
,
Doerthe Eckert
,
Sven Stodtmann
,
In-Ho Song
,
Peter Wung
,
Wei Liu
,
Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.
Clinical and translational science
17 (2) (2024)